Avidity Biosciences RNA reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Avidity Biosciences missed estimated earnings by 22.67%, reporting an EPS of $-0.92 versus an estimate of $-0.75.
Revenue was down $429 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09 which was followed by a 8.36% drop in the share price the next day.
Here's a look at Avidity Biosciences's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.80 | -0.70 | -0.68 | -0.71 |
EPS Actual | -0.71 | -0.82 | -0.68 | -0.70 |
Revenue Estimate | 1.90M | 2.17M | 2.12M | 1.94M |
Revenue Actual | 1.79M | 1.85M | 2.16M | 2.61M |
To track all earnings releases for Avidity Biosciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.